APEX | 340B Decision Means that the Government Is on the Spot to Determine the Fate of the ‘Rebate Model’

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.

With apologies to Inigo Montoya: Let me explain. No, there is too much. Let me sum up: President Biden and Bernie Sanders gave a joint press conference to tout all

There are two ways to think about this report from I-MAK that calculated that just four medicines -- Humira, Rituxan, Avastin and Lantus -- made more than $150 billion in